Phosphorylation: implications in cancer
V Singh, M Ram, R Kumar, R Prasad, BK Roy… - The protein journal, 2017 - Springer
Post translational modifications (PTMs) are involved in variety of cellular activities and
phosphorylation is one of the most extensively studied PTM, which regulates a number of …
phosphorylation is one of the most extensively studied PTM, which regulates a number of …
[HTML][HTML] Post-translational regulation of plant immunity
Highlights•Phosphorylation is a rapid and transient switch for PTI.•PTM links metabolic
pathways important for defense.•PTM of TSB1 counters pathogen virulence strategies.•PTM …
pathways important for defense.•PTM of TSB1 counters pathogen virulence strategies.•PTM …
[PDF][PDF] Functional lipidomics: Palmitic acid impairs hepatocellular carcinoma development by modulating membrane fluidity and glucose metabolism
L Lin, Y Ding, Y Wang, Z Wang, X Yin, G Yan… - …, 2017 - Wiley Online Library
Lipids are essential cellular components and energy sources of living organisms, and
altered lipid composition is increasingly recognized as a signature of cancer. We performed …
altered lipid composition is increasingly recognized as a signature of cancer. We performed …
Mitochondrial metabolites: undercover signalling molecules
C Frezza - Interface focus, 2017 - royalsocietypublishing.org
Mitochondria are one of most characterized metabolic hubs of the cell. Here, crucial
biochemical reactions occur and most of the cellular adenosine triphosphate (ATP) is …
biochemical reactions occur and most of the cellular adenosine triphosphate (ATP) is …
Site-specific incorporation of phosphotyrosine using an expanded genetic code
Access to phosphoproteins with stoichiometric and site-specific phosphorylation status is
key to understanding the role of protein phosphorylation. Here we report an efficient method …
key to understanding the role of protein phosphorylation. Here we report an efficient method …
Lapatinib resistance in breast cancer cells is accompanied by phosphorylation-mediated reprogramming of glycolysis
B Ruprecht, EA Zaal, J Zecha, W Wu, CR Berkers… - Cancer research, 2017 - AACR
Abstract HER2/ERBB2–overexpressing breast cancers targeted effectively by the small-
molecule kinase inhibitor lapatinib frequently acquire resistance to this drug. In this study …
molecule kinase inhibitor lapatinib frequently acquire resistance to this drug. In this study …
Tyrosine-nitrated proteins: proteomic and bioanalytical aspects
C Batthyány, S Bartesaghi… - Antioxidants & redox …, 2017 - liebertpub.com
Significance:“Nitroproteomic” is under active development, as 3-nitrotyrosine in proteins
constitutes a footprint left by the reactions of nitric oxide-derived oxidants that are usually …
constitutes a footprint left by the reactions of nitric oxide-derived oxidants that are usually …
Omics and exercise: global approaches for mapping exercise biological networks
NJ Hoffman - Cold Spring Harbor perspectives in …, 2017 - perspectivesinmedicine.cshlp.org
The application of global “-omics” technologies to exercise has introduced new opportunities
to map the complexity and interconnectedness of biological networks underlying the tissue …
to map the complexity and interconnectedness of biological networks underlying the tissue …
ATR inhibition facilitates targeting of leukemia dependence on convergent nucleotide biosynthetic pathways
TM Le, S Poddar, JR Capri, ER Abt, W Kim… - Nature …, 2017 - nature.com
Leukemia cells rely on two nucleotide biosynthetic pathways, de novo and salvage, to
produce dNTPs for DNA replication. Here, using metabolomic, proteomic, and …
produce dNTPs for DNA replication. Here, using metabolomic, proteomic, and …
MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)–addicted neuroblastomas
G Umapathy, J Guan, DE Gustafsson, N Javanmardi… - Science …, 2017 - science.org
Activation of the RAS-RAF-MEK-ERK signaling pathway is implicated in driving the initiation
and progression of multiple cancers. Several inhibitors targeting the RAS-MAPK pathway …
and progression of multiple cancers. Several inhibitors targeting the RAS-MAPK pathway …